14-day Premium Trial Subscription Try For FreeTry Free
$11.65
-0.110 (-0.94%)
At Close: May 08, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 8th May 2024 DVAX stock ended at $11.65. This is 0.94% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 1.76% from a day low at $11.64 to a day high of $11.85.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Dynavax Technologies Corporation prices

Date Open High Low Close Volume
May 27, 2016 $15.82 $15.94 $15.48 $15.85 392 239
May 26, 2016 $16.03 $16.17 $15.83 $15.85 425 167
May 25, 2016 $16.25 $16.49 $15.78 $16.10 479 714
May 24, 2016 $15.99 $16.50 $15.79 $16.12 464 814
May 23, 2016 $15.83 $16.71 $15.74 $15.89 691 100
May 20, 2016 $15.36 $15.76 $15.10 $15.71 503 233
May 19, 2016 $15.27 $15.63 $15.00 $15.21 328 491
May 18, 2016 $14.92 $15.52 $14.82 $15.33 334 844
May 17, 2016 $15.37 $15.55 $14.86 $14.96 546 025
May 16, 2016 $15.19 $15.93 $15.03 $15.50 599 777
May 13, 2016 $14.44 $15.48 $14.40 $15.22 667 824
May 12, 2016 $15.12 $15.29 $14.35 $14.47 683 232
May 11, 2016 $15.22 $15.71 $14.95 $15.00 510 088
May 10, 2016 $15.20 $15.98 $14.49 $15.32 988 947
May 09, 2016 $14.15 $15.39 $14.14 $15.07 883 715
May 06, 2016 $14.25 $14.36 $13.58 $14.09 877 651
May 05, 2016 $14.71 $14.97 $14.00 $14.38 995 696
May 04, 2016 $15.98 $16.02 $14.68 $14.94 1 675 450
May 03, 2016 $16.09 $16.54 $15.79 $16.08 875 237
May 02, 2016 $16.40 $16.60 $15.67 $16.22 1 393 172
Apr 29, 2016 $17.50 $17.70 $16.10 $16.41 1 521 459
Apr 28, 2016 $18.00 $18.36 $17.52 $17.53 1 095 156
Apr 27, 2016 $18.31 $18.96 $17.75 $18.53 3 580 585
Apr 26, 2016 $21.85 $21.85 $20.58 $20.98 533 921
Apr 25, 2016 $22.13 $22.38 $21.34 $21.61 556 108
Click to get the best stock tips daily for free!

About Dynavax Technologies Corporation

Dynavax Technologies Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a coll... DVAX Profile

Golden Star

Ticker Date Change Price
WMT May 06 0.718% $59.87
UNP May 06 2.80% $239.21
JPM May 06 1.90% $192.00
INGR May 03 3.40% $114.56
ADTH May 03 5.86% $3.24
ASH May 03 1.78% $95.85
BBCA May 03 0.99% $65.44
INVH May 03 0.90% $34.39
BNDX May 03 0.247% $48.68
INTU May 03 0.502% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT